Buprenorphine for Probationers and Parolees: Bridging the Gap Into Treatment

Paused · Phase 3

Conditions studied: Opioid Use

In brief

This five-year study will evaluate the effectiveness of the administration of buprenorphine bridge treatment (BBT) to probationers and parolees compared to treatment as usual (TAU), which consists of referral to a community buprenorphine treatment program.

Key facts

Study ID
NCT03616236
Run by
Friends Research Institute, Inc.
People needed
320
Starts
2022-07-01
Expected to finish
2026-12-30
Last updated by the study team
2026-02-03

Who can join

Age: 18 and older, up to 65. Sex: any. Healthy volunteers: accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.